Molecular Carcinogenesis

Papers
(The H4-Index of Molecular Carcinogenesis is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Immunogenic cell death in colon cancer prevention and therapy61
The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses55
MiR‐15a‐3p regulates ferroptosis via targeting glutathione peroxidase GPX4 in colorectal cancer39
Fibroblast growth factor‐2, derived from cancer‐associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling38
Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple‐negative breast cancer36
Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy36
Targeting glycosylated antigens on cancer cells using siglec‐7/9‐based CAR T‐cells35
Polyomavirus‐driven Merkel cell carcinoma: Prospects for therapeutic vaccine development32
PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma31
The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy31
Inhibition of Cathepsin D (CTSD) enhances radiosensitivity of glioblastoma cells by attenuating autophagy31
Circ0106714 inhibits tumorigenesis of colorectal cancer by sponging miR‐942‐5p and releasing DLG2 via Hippo‐YAP signaling29
Breast cancer stem cells: A review of their characteristics and the agents that affect them28
Redox regulation by SOD2 modulates colorectal cancer tumorigenesis through AMPK‐mediated energy metabolism27
M2‐like tumor‐associated macrophages‐secreted Wnt1 and Wnt3a promotes dedifferentiation and metastasis via activating β‐catenin pathway in thyroid cancer27
Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells27
Nicotinamide N‐methyltransferase decreases 5‐fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect25
Tocilizumab inhibits IL‐8 and the proangiogenic potential of triple negative breast cancer cells25
Alternative splicing related genetic variants contribute to bladder cancer risk25
EGFR‐ERK pathway regulates CSN6 to contribute to PD‐L1 expression in glioblastoma25
Transcriptome profiling reveals that VNPP433‐3β, the lead next‐generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial–mesenchymal transition and stem cell marker24
Saccharide analog, 2‐deoxy‐d‐glucose enhances 4‐1BB‐mediated antitumor immunity via PD‐L1 deglycosylation24
IL‐6 and IL‐8, secreted by myofibroblasts in the tumor microenvironment, activate HES1 to expand the cancer stem cell population in early colorectal tumor23
T‐cell receptor affinity in the age of cancer immunotherapy23
0.056337118148804